Literature DB >> 12867203

Factors associated with the receipt of treatment following detoxification.

Tami L Mark1, Joan D Dilonardo, Mady Chalk, RosannaM Coffey.   

Abstract

This paper examines the determinants of whether an individual received continuing treatment/rehabilitation services 30 days after receiving inpatient substance abuse detoxification. Data came from 1997-1999 employer health insurance claims. Only 49.4% of detoxification episodes were followed by continuing mental health or substance abuse treatment within 30 days after discharge. Some of the factors positively associated with receiving continuing treatment after receiving detoxification included: female gender, being in a behavioral health carve-out plan, and lower cost-sharing requirements for an outpatient substance abuse visit.

Entities:  

Mesh:

Year:  2003        PMID: 12867203     DOI: 10.1016/s0740-5472(03)00039-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  12 in total

Review 1.  Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Authors:  Paolo Mannelli; Kathleen S Peindl; Tong Lee; Kamal S Bhatia; Li-Tzy Wu
Journal:  Curr Drug Abuse Rev       Date:  2012-03

2.  Alcohol detoxification completion, acceptance of referral to substance abuse treatment, and entry into substance abuse treatment among Alaska Native people.

Authors:  Ursula Running Bear; Janette Beals; Douglas K Novins; Spero M Manson
Journal:  Addict Behav       Date:  2016-09-24       Impact factor: 3.913

3.  Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Authors:  Michael D Stein; Bradley J Anderson; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2015-07-14

4.  Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment.

Authors:  Bradley D Stein; Jane N Kogan; Mark Sorbero
Journal:  Drug Alcohol Depend       Date:  2009-05-29       Impact factor: 4.492

5.  A performance measure for continuity of care after detoxification: relationship with outcomes.

Authors:  Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds
Journal:  J Subst Abuse Treat       Date:  2014-05-02

6.  Design and impact of bundled payment for detox and follow-up care.

Authors:  Amity E Quinn; Dominic Hodgkin; Jennifer N Perloff; Maureen T Stewart; Mary Brolin; Nancy Lane; Constance M Horgan
Journal:  J Subst Abuse Treat       Date:  2017-09-21

7.  Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes.

Authors:  Elizabeth C Katz; Robert P Schwartz; Stuart King; David A Highfield; Kevin E O'Grady; Timothy Billings; Devang Gandhi; Eric Weintraub; David Glovinsky; Wardell Barksdale; Barry S Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.

Authors:  Genie L Bailey; Debra S Herman; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2013-06-18

9.  Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Li-Tzy Wu; Walter Ling; Bruce Burchett; Dan G Blazer; Jack Shostak; George E Woody
Journal:  Subst Abuse Rehabil       Date:  2010-12

10.  Managing addiction as a chronic condition.

Authors:  Michael Dennis; Christy K Scott
Journal:  Addict Sci Clin Pract       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.